In fact, Ma et al. [46] found in multiple human pancreatic cancer cell lines that IGF-1 treatment decreased phosphorylation of the tumor suppressor PTEN which lead to increased activation of PI3K/Akt and consequently, upregulation of NF-κB. This evidence concerns the gene IGF1 and pancreatic neoplasm.